HealthWay, a global provider of air purification solutions for both commercial and residential settings, has released laboratory results showing the company's high volume air purifiers capture and kill both bacteria and viruses with over 99.99 per cent efficiency.
HealthWay CEO, Jeff Pecoroni, said testing was undertaken on a variety of pathogens and conducted by two separate third-party laboratories.
"As employees return to the office, personal and business travel picks up, ensuring a safe, clean air environment is critical. HealthWay customers can be confident that their air quality meets the highest standards for a healthy environment,” he said.
The third party testing of HealthWay's high velocity Super V air purifiers covered sample bacteria and virus particles, including Staphylococcus epidermidis, a gram-positive bacterium used as a surrogate for Methicillin Resistant Staphylococcus aureus (MRSA), and MS2 ecoliphage, a single stranded RNA virus used as a surrogate for SARS-CoV 2.
The company's in-line Super V air purifiers are installed in HVAC ducts, typically in commercial settings or for whole-home residential installations.
HealthWay provides a comprehensive offering of modular, scalable, efficient, portable and in-line air cleaning solutions for any indoor environment, as well as replacement filters.
HealthWay's proprietary solutions feature its patented, state-of-the-art Disinfecting Filtration System (DFS) technology, which has been proven to capture and permanently remove airborne viruses and bacteria. Its products are sold under the brands HealthWay, Intellipure, and Pure Wellness.